63 related articles for article (PubMed ID: 8690825)
1. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.
Prueksaritanont T; Ma B; Tang C; Meng Y; Assang C; Lu P; Reider PJ; Lin JH; Baillie TA
Br J Clin Pharmacol; 1999 Mar; 47(3):291-8. PubMed ID: 10215754
[TBL] [Abstract][Full Text] [Related]
2. Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.
Ghosh C; Hossain M; Spriggs A; Ghosh A; Grant GA; Marchi N; Perucca E; Janigro D
Epilepsia; 2015 Mar; 56(3):439-49. PubMed ID: 25656284
[TBL] [Abstract][Full Text] [Related]
3. QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors.
Berger FA; Monadian N; de Groot NMS; Santbergen B; van der Sijs H; Becker ML; Broers AEC; van Gelder T; van den Bemt PMLA
Br J Clin Pharmacol; 2018 Feb; 84(2):369-378. PubMed ID: 29057492
[TBL] [Abstract][Full Text] [Related]
4. Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.
Kristóf A; Husti Z; Koncz I; Kohajda Z; Szél T; Juhász V; Biliczki P; Jost N; Baczkó I; Papp JG; Varró A; Virág L
PLoS One; 2012; 7(12):e53255. PubMed ID: 23300901
[TBL] [Abstract][Full Text] [Related]
5. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity.
Khojasteh SC; Prabhu S; Kenny JR; Halladay JS; Lu AY
Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):1-16. PubMed ID: 21336516
[TBL] [Abstract][Full Text] [Related]
6. Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.
Culm-Merdek KE; von Moltke LL; Harmatz JS; Greenblatt DJ
Br J Clin Pharmacol; 2005 Nov; 60(5):486-93. PubMed ID: 16236038
[TBL] [Abstract][Full Text] [Related]
7. Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses.
Nagy CF; Kumar D; Perdomo CA; Wason S; Cullen EI; Pratt RD
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):25-33. PubMed ID: 15496220
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the clinical development of cytochrome p450 3A substrates.
Gibbs MA; Hosea NA
Clin Pharmacokinet; 2003; 42(11):969-84. PubMed ID: 12908853
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine.
Kosoglou T; Salfi M; Lim JM; Batra VK; Cayen MN; Affrime MB
Br J Clin Pharmacol; 2000 Dec; 50(6):581-9. PubMed ID: 11136297
[TBL] [Abstract][Full Text] [Related]
10. Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
Jurima-Romet M; Wright M; Neigh S
Br J Clin Pharmacol; 1998 Mar; 45(3):318-21. PubMed ID: 10896409
[TBL] [Abstract][Full Text] [Related]
11. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
Venkatakrishnan K; von Moltke LL; Greenblatt DJ
Clin Pharmacokinet; 2000 Feb; 38(2):111-80. PubMed ID: 10709776
[TBL] [Abstract][Full Text] [Related]
12. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
Damkier P; Hansen LL; Brosen K
Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487
[TBL] [Abstract][Full Text] [Related]
13. Inhibition and induction of cytochrome P450 and the clinical implications.
Lin JH; Lu AY
Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089
[TBL] [Abstract][Full Text] [Related]
14. Drug interactions of clinical significance with selective serotonin reuptake inhibitors.
Mitchell PB
Drug Saf; 1997 Dec; 17(6):390-406. PubMed ID: 9429838
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
Debruyne D
Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
[TBL] [Abstract][Full Text] [Related]
16. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.
Bertz RJ; Granneman GR
Clin Pharmacokinet; 1997 Mar; 32(3):210-58. PubMed ID: 9084960
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.
von Moltke LL; Greenblatt DJ; Duan SX; Harmatz JS; Wright CE; Shader RI
J Clin Psychopharmacol; 1996 Apr; 16(2):104-12. PubMed ID: 8690825
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin.
Desta Z; Soukhova N; Flockhart DA
J Clin Psychopharmacol; 2002 Apr; 22(2):162-8. PubMed ID: 11910261
[TBL] [Abstract][Full Text] [Related]
19. Midazolam hydroxylation by human liver microsomes in vitro: inhibition by fluoxetine, norfluoxetine, and by azole antifungal agents.
von Moltke LL; Greenblatt DJ; Schmider J; Duan SX; Wright CE; Harmatz JS; Shader RI
J Clin Pharmacol; 1996 Sep; 36(9):783-91. PubMed ID: 8889898
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
